ARAMCHOL SALTS

CRYSTALLINE PHASES OF 5,6-DICHLORO-2-(ISOPROPYLAMINO)-(1-BETA-L-RIBOFURANOSYL)-1H-BENZIMIDAZOLE

COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER

Substituted aza-bicyclic imidazole derivatives useful TRPM8 receptor modulators

Crystalline forms of N-(4-((3-(2-amino-4-pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(4-methyl-2-thienyl)-1-phthalazinamine salts and uses thereof

Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide

Solid form of abiraterone acetate

Method for preparing crystalline insulin

Process for the preparation of dicycloplatin

Efficient method for the preparation of tofacitinib citrate

Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof

Preparation of cobicistat intermediates

Crystalline forms of lesinurad and its sodium salt

Methods of synthesizing substituted purine compounds

Processes of making and crystalline forms of a MDM2 inhibitor

Crystalline forms of temozolomide and the method for preparing same

IVABRADINE HYDROCHLORIDE FORM IV

Processes of making and crystalline forms of a MDM2 inhibitor

Selective FKBP51 ligands for treatment of psychiatric disorders

Calcium propane-2-sulfinate dihydrate

CRYSTALLINE FORMS B, C, and D OF CANAGLIFLOZIN

Synthesis of trans-8-chloro-5-methyl-1-[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H-2,3,5,10B-tetraaza-benzo[E]azulene and crytalline forms thereof

Solid state forms of a quinazoline derivative and its use as a BRAF inhibitor

Solid forms of Ivacaftor and processes for the preparation thereof

Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto

Treatment of diseases through administration of N-[5-(3,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide

Chitin nanocrystals and process for preparation thereof

Cyclosporin a form 2 and method of making same

Partially Crystalline Glucamide Compositions And Method For Preparing Same

Processes for producing diazabicyclooctane compounds

Crystal form of (R)-praziquantel and preparation method and application thereof

Methods for the preparation of charged crosslinkers

Metal-organic materials and method for preparation

Metal complexes and methods of treatment

Tetrapeptide compound and method for producing same

Purinone derivative hydrochloride

SALT OF NAPHTHYRIDINE CARBOXYLIC ACID DERIVATIVE

CRYSTALLINE DASATINIB PROCESS

Processes of making and crystalline forms of a MDM2 inhibitor

Salts and processes of preparing a PI3K inhibitor

NOVEL COMPOUNDS

CRYSTALLINE SOLVATE FORMS OF CABAZITAXEL

Stable polymorph of the salt of (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-α]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-anime with L-tartaric acid

Crystalline form of 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1, 3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenylmethanesulphonate

2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-N[4-(trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzenesulfonate, crystal of same, crystal polymorph thereof, and methods for production thereof

Process for Regorafenib

CRYSTALLINE FORM OF PEMIROLAST

Process of making regadenoson and novel polymorph thereof

CRYSTALLINE FORMS OF A MACROLIDE, AND USES THEREFOR

Process for the trans-selective hydroboration of internal alkynes

Crystals of dispiropyrrolidine derivatives

Processes for preparing ASK1 inhibitors

Carbamate/urea derivatives

Crystalline anhydrous form of Cabazitaxel, process for the preparation and pharmaceutical compositions thereof

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

Method of synthesizing thyroid hormone analogs and polymorphs thereof

CRYSTALLINE BROMODOMAIN INHIBITORS

Hydrochloride salt form for EZH2 inhibition

Crystal modifications of elobixibat

KDM1A inhibitors for the treatment of disease

Process to manufacture N-[(3S)-1-[4-[(3-fluorophenyl)methoxy]phenyl]-5-oxo-pyrrolidin-3-yl]acetamide

Method for preparing a sitagliptin intermediate

Crystal modifications of elobixibat

Salt of nitrogen-containing heterocyclic compound or crystal thereof, pharmaceutical composition, and FLT3 inhibitor

Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

Process for obtaining methionine

()-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid

Crystalline form of 1-(beta-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene and preparation method thereof

Polymorphs of 2-(4-(2-(1-(isopropyl-3-methyl-1H-1,2,4,triazol-5-yl)-5,6-dihydrobenzo[f] imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide, methods of production, and pharmaceutical uses thereof

Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2

Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

Crystalline CHClNOmalonate

Crystalline phase of (3S,3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) with L-lysine

Method for producing a crystalline solid from glycine-N, N-diacetic acid derivatives with sufficiently reduced hygroscopicity

Preparation and uses of obeticholic acid

4-{4-[(1E)-4-(2,9-diazaspiro[5.5]undec-2-yl)but-1-en-1-yl]-2-methylbenzyl}-5-(propan-2-yl)-1H-pyrazol-3-yl beta-D glucopyranoside acetate

Crystalline maltitol powder less prone to consolidation and method for production thereof

Crystal form of dabrafenib and preparation method and use thereof

COBICISTAT DICHLOHYDRATE SALT

CRYSTALLINE SALTS OF (4S, 4AS, 5AR, 12AS)-4-DIMETHYLAMINO-3,10,12,12A-TETRAHYDROXY-7-[(METHOXY(METHYL)AMINO)-METHYL]-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-NAPHTHACENE-2-CARBOXYLIC ACID AMIDE AND METHODS OF USING THE SAME

Process for preparing cinacalcet and pharmaceutically acceptable salts thereof

Form 2 crystalline polymorph of a salt of N-[1-6-(ethynyl-3-oxo-hexahydro-furo[3,2-B]pyrrole-4-carbonyl)-3-methyl-butyl]-4-[5-fluoro-2-(4-methyl-piperazinyl) thiazol-4-yl]-benzamide useful as cysteine protease inhibitor

Crystal of 6,7-unsaturated-7-carbamoyl morphinan derivative and method for producing the same

Therapeutically active compounds and their methods of use

Deuterated diaminopyrimidine compounds and pharmaceutical compositions comprising such compounds

Preparation and uses of obeticholic acid

Novel Ticagrelor Co-Crystal

Process for making beta 3 agonists and intermediates

Short-acting benzodiazepine salts and their polymorphic forms

CRYSTALLINE FORMS OF NEUROTROPHIN MIMETIC COMPOUNDS AND THEIR SALTS

Crystalline forms of bimatoprost acid, methods for preparation, and methods for use thereof

Crystalline forms of pemetrexed tromethamine salts

Salts of Dasatinib in crystalline form

Crystalline forms of a biphenyl compound

Preparation of and formulation comprising a MEK inhibitor

Preparation of and formulation comprising a MEK inhibitor

Preparation of and formulation comprising a MEK inhibitor

Forms of co-crystals of agomelatine and p toluenesulphonic acid, a process for their preparation and pharmaceutical compositions containing them

5-bromo-2-(alpha-hydroxypentyl)benzoic acid sodium salts in different crystal forms, and preparation method thereof

Co-crystal of the PAR-1 receptor antagonists vorapaxar and aspirin

Benzoimidazol-2-yl pyrimidine modulators of the histamine Hreceptor

Polymorphs of N- (2 -methoxybenzoyl) -4- [ (methylaminocarbonyl) amino] benzenesulfonamide

Crystalline hydrates of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene

Dolutegravir salts

Polymorphic forms of icotinib phosphate and uses thereof

Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursors

Processes for the preparation of prostaglandin amides

Crystalline freebase forms of a biphenyl compound

Polymorphic forms of icotinib maleate and uses thereof

Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate

Processes for the preparation of prostaglandin amides

Chemical compounds

Method for producing beta-hematin crystal comprising step of heating

Crystalline forms of pemetrexed diacid and manufacturing processes therefor

Polymorphs

CRYSTALLINE IMATINIB MESYLATE PROCESS

Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride

Polymorph of regadenoson

Crystalline forms of therapeutic compounds and uses thereof

Preparation and uses of obeticholic acid

Polymorphic forms of ST-246 and methods of preparation

Synthesis of triethylenetetramines

Galactoside inhibitor of galectins

Crystalline form of -dicyclopropyl-4-(1,5-dimethyl-1-pyrazol-3-ylamino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-D]pyrrolo[2,3-B]pyridine-7-carboxamide for the treatment of myeloproliferative disorders

CO-CRYSTALS OF LAPATINIB MONOACID SALTS

CRYSTALLINE FORM OF CYCLOSPORIN A, METHODS OF PREPARATION, AND METHODS FOR USE THEREOF

Polymorph forms

POLYMORPHIC FORMS OF LOMITAPIDE AND ITS SALTS AND PROCESSES FOR THEIR PREPARATION

Process for the preparation of arformoterol or salt thereof

Crystal form

Process for the Preparation of (-)-(4-Chloro-Phenyl)-(3-Trifluoromethyl-Phenoxy)-Acetic Acid 2-Acetylamino-Ethyl Ester

Preparation and uses of obeticholic acid

Method for isolating caspofungin

Polymorphs and amorphous forms of 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile

Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide

Method of producing therapeutic agent

Solubilization of pterostilbene and resveratrol in aqueous beverages

Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives

Salt of pyrazoloquinoline derivative, and crystal thereof

Crystalline Forms of D-Glucitol, 1-Deoxy-1-(Methylamino)-, 1-(6-Amino-3,5-Difluoropyridine-2-Yl)-8-Chloro-6-Fluoro-1,4-Dihydro-7-(3-Hydroxyazetidin-1-Yl)-4-Oxo-3-Quinolinecarboxylate

Preparation and method for use in the treatment of respiratory diseases

CRYSTALS OF LAQUINIMOD SODIUM AND IMPROVED PROCESS FOR THE MANUFACTURE THEREOF

Method for the preparation of (3S,3S′) 4,4′-disulfanediylbis (3-aminobutane 1-sulfonic acid)

Pharmaceutically acceptable salts and polymorphic forms of hydrocodone benzoic acid enol ester and processes for making same

Crystalline form of an anxiolytic compound

Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof

FORMS OF RIFAXIMIN AND USES THEREOF

Form of pyrimidine compound having dibenzylamine structure

Stable solid forms of regadenoson

Methods of synthesizing substituted purine compounds

Process for preparing chiral dipeptidyl peptidase-IV inhibitors

SALTS AND SOLID FORMS OF ISOQUINOLINONES AND COMPOSITION COMPRISING AND METHODS OF USING THE SAME

Polymorph forms of desazadesferrithiocin analogs

CRYSTALLINE FORMS OF PITAVASTATIN CALCIUM

Pyrazolopyrimidine compounds

Sodium (2R,5S,13aR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2, 1-b][1, 3]oxazepin-8-olate

Amorphous form of 4-((4-(cyclopentyloxy)-5-(2-methylbenzo[d]oxazol-6-yl)-7h-pyrrolo[2,3-d]pyrimidin-2-yl)amino)-3-methoxy-n-methylbenzamide, compositions thereof and methods of their use

Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate

Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both β2 adrenergic receptor agonist and M3 muscarinic receptor antagonist activities

1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-I-yl) ureas as P38 mapkinase inhibitors

Process for preparing substituted 5-fluoro-1H-pyrazolopyridines

Crystalline forms of pemetrexed diacid and processes for the preparation thereof

POLYMORPHS AND SALTS OF A COMPOUND

Process for preparation of (2S, 5R)-7-oxo-6-sulphooxy-2-[((3R)-pyrrolidine-3-carbonyl)-hydrazino carbonyl]-1,6-diaza-bicyclo[3.2.1]octance

Process for the preparation of substituted oxiranes and triazoles

Crystalline forms of tyrosine kinase inhibitors and their salts

Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2′-methyl-1,1′-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methyloxime, and methods of using the same

Tromethamine salt of bimatoprost acid in crystalline form 1, methods for preparation, and methods for use thereof

New 3,3',5,5'-Tetraisopropyl-4,4'-Diphenol Crystal Form And Preparation Method Thereof

METHODS OF PREPARING SUBSTITUTED NUCLEOTIDE ANALOGS

Polymorphous forms III and IV of N-benzoyl-staurosporine

Lamivudine salts

Crystalline forms of (2R,5S,13AR)-8-hydroxy-7,9,-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide

Morphine Sulfate Methanolic Solvate, Processes for Making Same and Related Compositions and Methods for Treating Pain

Process for preparing a diamine/dicarboxylic acid salt

Pemetrexed Complexes and Pharmaceutical Compositions Containing Pemetrexed Complexes

Intermediate and polymorphs of 1-(4-methoxypheny1)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetra hydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide and process thereof

Salts and crystal forms

Process for preparing the anti-tumor agent 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide and its crystalline

Salts of Saxagliptin with organic acids

CRYSTALLINE FORM OF y-AMINOBUTYRIC ACID ANALOG

Crystalline form of VSN16

Crystalline particles of salts of glutamic acid N,N-diacetic acid

Solid forms of an antiviral compound

Nicotine salts, co-crystals, and salt co-crystal complexes

Process for the preparation of fingolimod and its salts

Monoclinic crystalline form of asenapine maleate with a specific particle size distribution

Process For The Preparation Of A DPP-IV Inhibitor

LFA-1 inhibitor and methods of preparation and polymorph thereof

Complex of glucose derivative and proline, crystal, preparation method and use

Zinc-lysine complex

NOVEL CRYSTALLINE FORM OF TICAGRELOR AND PROCESS FOR THE PREPARATION THEREOF

Process for producing Sovaprevir

11-2(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt

Nitrogen containing compounds and their use

Polymorph forms

Crystalline particles of glutamic acid N,N-diacetic acid

Perovskite material layer processing

Halichondrin B analogs

Crystalline forms of 3-(imidazo[1,2-B] pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl) methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt

Compositions for modulating a kinase cascade and methods of use thereof

Bicyclic compounds

Glyphosate dimethylamine salt crystal, preparation method and use thereof

Crystal form of Dabrafenib and preparation method of use thereof

Process for the preparation of a stable polymorphic form of Atovaquone

Solid forms comprising 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one, and a coformer, compositions and methods of use thereof

Salts and polymorphs of a substituted imidazopyridinyl-aminopyridine compound

CRYSTALLINE FORMS OF (1S)-1-[5-(AMINO)-1,2,4-THIADIAZOL-3-YL]ETHANE-1,2-DIOL

Solid forms of {s-3-(4-amino-1-oxo-isoindolin-2-yl)(piperidine-3,4,4,5,5-d)-2,6-dione}

POLYMORPH FORMS OF DESAZADESFERRITHIOCIN ANALOGS

Crystalline erlotinib hydrochloride process

Crystal containing unsaturated carboxylic acid amide compound and method for producing same

Crystal form of chidamide, preparation method and use thereof

Process for preparing lacosamide and related compounds

Solid state forms of tapentadol salts

Processes for production of intermediates for 2-alkyl cephem compounds

PROCESS FOR THE PREPARATION OF POLYMORPHS OF DORIPENEM

NOVEL POLYMORPHS OF AZILSARTAN

2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-N-[4-(trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzenesulfonate, crystal of same, crystal polymorph thereof, and methods for production thereof

Amorphous form of quinoline derivative, and method for producing same

PROCESS FOR THE PREPARATION OF CRYSTALLINE FORM OF AGOMELATINE

Crystalline forms of genistein

Method for crystallization of TRX-TXNIP complex mutein and 3D structure thereof

Formulation of 5-azacytidine

Solid salt form of α-6-mPEG-O-hydroxycodone as opioid agonists and uses thereof

SUBSTITUTED INDOLE DERIVATIVES

Crystalline phase of (3S.3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) with L-lysine

Method for producing reduced coenzyme Q10

Galactoside inhibitor of galectin-3 and its use for treating pulmonary fibrosis

Salt and polymorphic forms of (3R,4S)-L-((4-amino-5H-pyrrolo[3,2,-d]pyrimidin-7-yl)methyl)-4(methylthiomethyl)pyrodin-3-ol(MTDIA)

Preparation of ertapenem intermediates

Unsolvated crystalline form 1 of N-[5-(3, 5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide and methods of use thereof

Solid forms of nilotinib hydrochloride

Methods for making polymorphs of bromfenac sodium and bromfenac sodium formulations

Solid dispersion with improved solubility comprising tetrazole derivative as an active ingredient

CRYSTALLINE FORM OF A DRUG

Crystalline forms of a factor XIa inhibitor

SODIUM SALT OF 6-FLUOR0-3-HYDROXY-2-PYRAZINE CARBOXAMIDE

Form-III crystal of 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide and use thereof

Polymorphs of deuterated omega-diphenylurea or salts thereof

Crystalline bortezomib process

Salt crystals

Method for producing sulfonyl amidine compound

CRYSTALLINE FORMS OF NEUROTROPHIN MIMETIC COMPOUNDS AND THEIR SALTS

PREPARATION OF GGA AND DERIVATIVES THEREOF AND THEIR CO-CRYSTALLIZATION WITH UREA OR THIOUREA

Solid forms of a pyrido-pyrimidinium inner salt

Iohexol powder and method of using the same

Crystalline polymorphic form of ulipristal acetate

Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt

Crystalline polymorphic form of ulipristal acetate

Methods of treating a fatty acid amide hydrolase-mediated condition

ENZALUTAMIDE POLYMORPHIC FORMS AND ITS PREPARATION

4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2(2-pyrimidinyl)-pyrimidine-4-yl)-benzen esulfonamide sodium

Structure refining apparatus, method and program

Solid forms of tofacitinib salts

Pyrazolopyrimidine compounds

Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde

Low hygroscopic aripiprazole drug substance and processes for the preparation thereof

Acetamide stereoisomer

Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto

Amorphous mirabegron and processes for crystal forms of mirabegron

Polymorphic forms of naltrexone

CRYSTALLINE FORMS OF THALIDOMIDE AND PROCESSES FOR THEIR PREPARATION

Amine salt and crystals thereof

Process for producing compositions rich in crystals of mannitol in delta form, compositions and crystals obtained and uses thereof

Aniline type compounds

Certain compounds, compositions and methods

Hydrochloride salts of 8-[1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diazaspiro[4,5]decan-2-one and preparation process therefor

Preparation of hydroxy-benzylbenzene derivatives

Multi plane mixer and separator (MPMS) system

Process for preparation of Darunavir

Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide

SOLID FORMS COMPRISING INHIBITORS OF HCV NS5A, COMPOSITIONS THEREOF, AND USES THEREWITH

Method of synthesizing thyroid hormone analogs and polymorphs thereof

Process for the preparation of (2Z,5Z)-5-(3-chloro-4-(()-2,3-dihydroxypropdxy)benzylidene)-2-(propylimino)-3-(-tolyl)thiazolidin-4-one and intermediate used in said process

POLYMORPHS OF N-((S)-3-AMINO-1-(HYDROXYAMINO)-3-METHYL-1-OXOBUTAN-2-YL)-4-(((1R,2R)-2-(HYDROXYMETHYL)CYCLOPROPYL)BUTA-1,3-DIYNYL)BENZAMIDE

Modified release formulations of a bupropion salt

Solid forms of tenofovir

Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts

Crystalline polymorphic forms of an antidiabetic compound

Polymorphs of N-[(R)-1-[(S)-1-(4-aminomethyl-benzylcarbamoyl)-2-phenyl-ethylcarbamoyl]-2-(4-ethoxy-phenyl)-ethyl]-benzamide hydrochloride

Crystalline forms of 1-(5′-(5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoro-methyl)-4,5-dihydroisoxazol-3-yl)-3′H-spiro[azetidine-3,1′-isobenzofuran]-1-yl)-2-(methylsulfonyl) ethanone

Polymorphs of azilsartan medoxomil

Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal

Process for the preparation of nilotinib

Crystalline salts of (Z)-O-octadec-9-en-1-yl O,O-dihydrogen phosphorothioate

Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and pharmaceutical composition prepared by containing the crystal

Forms of cidofovir

CRYSTAL FORMS

Salts and hydrates of antipsychotics

Highly pure bendamustine hydrochloride monohydrate

Multicomponent crystalline system comprising deferasirox and isonicotinamide and a process for the preparation thereof

Method for preparing high-content zeaxanthin

Crystalline forms of tyrosine kinase inhibitors and their salts

Polymorphic forms of a steroid-like compound and methods for the preparation and use thereof

Polymorphs of 2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazole-5-yl)-5,6-dihydrobenzo[F]imidazo [1,2-D][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide, methods of production, and pharmaceutical uses thereof

Synthesis of oxycodone hydrochloride

Crystalline salts of a potent HCV inhibitor

Crystal forms of 5-[3-(2,5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl)[1,2,4]oxadiazol-5-yl]-3-nitrobenzene-1,2-diol